English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 10, 2026

PepGen shares fall after mixed results in muscle-wasting disease trial
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Eli Lilly announces $6.3 billion acquisition of Centessa Pharmaceuticals to expand sleep disorder pipeline
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Sanofi, Incyte, Roivant and Alumis present new skin disease data at AAD 2026
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Biogen announces $5.6 billion acquisition of Apellis Pharmaceuticals for kidney disease expansion
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Viridian Therapeutics reports mixed results in thyroid eye disease study
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Researchers identify markers of lymphoma recurrence
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Study finds planetary health diet meets key nutrient needs in early pregnancy
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Researchers develop stem cell therapy for Hirschsprung disease in UK collaboration

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones